• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马传染性贫血病毒在持续感染期间体内包膜的进化逐渐增加对体外血清抗体中和的抗性,这是一种主要表型。

Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

作者信息

Howe Laryssa, Leroux Caroline, Issel Charles J, Montelaro Ronald C

机构信息

Department of Infectious Disease and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

出版信息

J Virol. 2002 Nov;76(21):10588-97. doi: 10.1128/jvi.76.21.10588-10597.2002.

DOI:10.1128/jvi.76.21.10588-10597.2002
PMID:12368301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC136617/
Abstract

Equine infectious anemia virus (EIAV) infection of horses is characterized by well-defined waves of viremia associated with the sequential evolution of distinct viral populations displaying extensive envelope gp90 variation; however, a correlation of in vivo envelope evolution with in vitro serum neutralization phenotype remains undefined. Therefore, the goal of the present study was to utilize a previously defined panel of natural variant EIAV envelope isolates from sequential febrile episodes to characterize the effects of envelope variation during persistent infection on viral neutralization phenotypes and to define the determinants of EIAV envelope neutralization specificity. To assess the neutralization phenotypes of the sequential EIAV envelope variants, we determined the sensitivity of five variant envelopes to neutralization by a longitudinal panel of immune serum from the source infected pony. The results indicated that the evolution of the EIAV envelope sequences observed during sequential febrile episodes produced an increasingly neutralization-resistant phenotype. To further define the envelope determinants of EIAV neutralization specificity, we examined the neutralization properties of a panel of chimeric envelope constructs derived from reciprocal envelope domain exchanges between selected neutralization-sensitive and neutralization-resistant envelope variants. These results indicated that the EIAV gp90 V3 and V4 domains individually conferred serum neutralization resistance while other envelope segments in addition to V3 and V4 were evidently required for conferring total serum neutralization sensitivity. These data clearly demonstrate for the first time the influence of sequential gp90 variation during persistent infection in increasing envelope neutralization resistance, identify the gp90 V3 and V4 domains as the principal determinants of antibody neutralization resistance, and indicate distinct complex cooperative envelope domain interactions in defining sensitivity to serum antibody neutralization.

摘要

马感染马传染性贫血病毒(EIAV)的特征是出现明确的病毒血症波,这与不同病毒群体的顺序演变相关,这些病毒群体显示出广泛的包膜糖蛋白90(gp90)变异;然而,体内包膜进化与体外血清中和表型之间的相关性仍不明确。因此,本研究的目的是利用先前定义的一组来自连续发热期的天然变异EIAV包膜分离株,来表征持续感染期间包膜变异对病毒中和表型的影响,并确定EIAV包膜中和特异性的决定因素。为了评估连续的EIAV包膜变异体的中和表型,我们通过来自感染源小马的纵向免疫血清组,测定了五种变异包膜对中和作用的敏感性。结果表明,在连续发热期观察到的EIAV包膜序列的进化产生了越来越抗中和的表型。为了进一步确定EIAV中和特异性的包膜决定因素,我们检查了一组嵌合包膜构建体的中和特性,这些构建体源自选定的中和敏感和中和抗性包膜变异体之间的相互包膜结构域交换。这些结果表明,EIAV gp90的V3和V4结构域单独赋予血清中和抗性,而除V3和V4之外的其他包膜片段显然是赋予总血清中和敏感性所必需的。这些数据首次清楚地证明了持续感染期间连续的gp90变异在增加包膜中和抗性方面的影响,确定了gp90 V3和V4结构域是抗体中和抗性的主要决定因素,并表明在定义对血清抗体中和的敏感性方面存在明显的复杂协同包膜结构域相互作用。

相似文献

1
Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.马传染性贫血病毒在持续感染期间体内包膜的进化逐渐增加对体外血清抗体中和的抗性,这是一种主要表型。
J Virol. 2002 Nov;76(21):10588-97. doi: 10.1128/jvi.76.21.10588-10597.2002.
2
Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain.对感染中和抗性马传染性贫血病毒包膜毒株的隐性携带小马进行短暂免疫抑制所诱导的血清中和抗体的特异性
J Gen Virol. 2005 Jan;86(Pt 1):139-149. doi: 10.1099/vir.0.80374-0.
3
Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.与实验感染小马连续疾病周期相关的马传染性贫血病毒基因组准种的新型动态演变
J Virol. 1997 Dec;71(12):9627-39. doi: 10.1128/JVI.71.12.9627-9639.1997.
4
Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.进行性和非进行性小马中马传染性贫血病毒的基因组进化
J Virol. 2001 May;75(10):4570-83. doi: 10.1128/JVI.75.10.4570-4583.2001.
5
Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.受体小马的马传染性贫血病毒(EIAV)体液反应及持续感染期间的抗原变异
Arch Virol. 1990;111(3-4):199-212. doi: 10.1007/BF01311054.
6
Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.利用单克隆抗体对马传染性贫血病毒(EIAV)变异株进行抗原分析:EIAV糖蛋白gp90的表位刺激中和抗体产生。
J Virol. 1987 Oct;61(10):2956-61. doi: 10.1128/JVI.61.10.2956-2961.1987.
7
Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.对感染主要中和结构域缺陷型马传染性贫血病毒的隐性携带者进行短暂免疫抑制,可诱导产生中和抗体并降低稳态病毒复制。
J Gen Virol. 2002 Jun;83(Pt 6):1353-1359. doi: 10.1099/0022-1317-83-6-1353.
8
Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.马传染性贫血病毒包膜蛋白的抗原图谱:糖蛋白90上中和结构域和保守区域的鉴定
Arch Virol. 1988;98(3-4):213-24. doi: 10.1007/BF01322170.
9
Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli.
Virology. 1989 Oct;172(2):609-15. doi: 10.1016/0042-6822(89)90203-1.
10
In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV).
Arch Virol. 1990;111(3-4):275-80. doi: 10.1007/BF01311062.

引用本文的文献

1
diversity-dependent protection of the attenuated equine infectious anaemia virus vaccine.依赖多样性的减毒马传染性贫血病毒疫苗保护。
Emerg Microbes Infect. 2020 Dec;9(1):1309-1320. doi: 10.1080/22221751.2020.1773323.
2
High Genomic Variability in Equine Infectious Anemia Virus Obtained from Naturally Infected Horses in Pantanal, Brazil: An Endemic Region Case.巴西潘塔纳尔自然感染马中获得的马传染性贫血病毒的高基因组变异性:一个地方性流行地区案例。
Viruses. 2020 Feb 12;12(2):207. doi: 10.3390/v12020207.
3
Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.中国马传染性贫血病毒疫苗株env gp90蛋白中修饰N-连接糖基化的氨基酸突变增强了对中和抗体的抗性。
Virus Genes. 2016 Dec;52(6):814-822. doi: 10.1007/s11262-016-1382-2. Epub 2016 Aug 29.
4
Genetic Evolution during the development of an attenuated EIAV vaccine.减毒马传染性贫血病毒疫苗研发过程中的基因进化
Retrovirology. 2016 Feb 3;13:9. doi: 10.1186/s12977-016-0240-6.
5
Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.减毒马慢病毒疫苗中集中式和多价包膜免疫原的保护效力
PLoS Pathog. 2015 Jan 8;11(1):e1004610. doi: 10.1371/journal.ppat.1004610. eCollection 2015 Jan.
6
Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.从马传染性贫血病毒感染与免疫研究中得到的艾滋病疫苗开发经验教训。
Viruses. 2013 Dec 2;5(12):2963-76. doi: 10.3390/v5122963.
7
Envelope determinants of equine lentiviral vaccine protection.马慢病毒疫苗保护的信封决定因素。
PLoS One. 2013 Jun 13;8(6):e66093. doi: 10.1371/journal.pone.0066093. Print 2013.
8
Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.高通量、半自动、基于感染中心细胞的 ELISA 检测方法的建立及其在马传染性贫血病毒检测中的应用。
J Virol Methods. 2012 Nov;185(2):221-7. doi: 10.1016/j.jviromet.2012.07.007. Epub 2012 Jul 20.
9
Decreased infectivity of a neutralization-resistant equine infectious anemia virus variant can be overcome by efficient cell-to-cell spread.耐中和性的马传染性贫血病毒变异株的感染力降低可通过有效的细胞间传播来克服。
J Virol. 2011 Oct;85(19):10421-4. doi: 10.1128/JVI.05349-11. Epub 2011 Jul 13.
10
Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.马传染性贫血病毒强毒株EIAV(LN₄₀)包膜蛋白的独特进化特征
Virus Genes. 2011 Apr;42(2):220-8. doi: 10.1007/s11262-010-0563-7. Epub 2011 Jan 8.

本文引用的文献

1
Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.对感染主要中和结构域缺陷型马传染性贫血病毒的隐性携带者进行短暂免疫抑制,可诱导产生中和抗体并降低稳态病毒复制。
J Gen Virol. 2002 Jun;83(Pt 6):1353-1359. doi: 10.1099/0022-1317-83-6-1353.
2
HIV gp120 V(1)/V(2) and C(2)-V(3) domains glycoprotein compatibility is required for viral replication.HIV gp120的V(1)/V(2)和C(2)-V(3)结构域糖蛋白兼容性是病毒复制所必需的。
Virus Res. 2001 Nov 5;79(1-2):91-101. doi: 10.1016/s0168-1702(01)00322-7.
3
Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.进行性和非进行性小马中马传染性贫血病毒的基因组进化
J Virol. 2001 May;75(10):4570-83. doi: 10.1128/JVI.75.10.4570-4583.2001.
4
Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys.通过在猴子体内传代获得的猿猴-人类免疫缺陷病毒(SHIV-HXBc2P 3.2)中中和抗性的包膜糖蛋白决定簇
J Virol. 2001 May;75(9):4208-18. doi: 10.1128/JVI.75.9.4208-4218.2001.
5
Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course.一名意外感染的实验室工作人员感染了1型人类免疫缺陷病毒IIIB株,该病毒株转变为具有中和抗性表型,且临床病程呈进行性发展。
J Virol. 2001 Mar;75(5):2246-52. doi: 10.1128/JVI.75.5.2246-2252.2001.
6
Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo.猿猴-人类免疫缺陷病毒体内传代过程中,包膜糖蛋白gp120的V2和V3环结构变化与中和抗性获得之间的关联
J Virol. 2000 Dec;74(24):11955-62. doi: 10.1128/jvi.74.24.11955-11962.2000.
7
Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.接种马传染性贫血病毒的长期隐性携带小马的免疫反应和病毒复制
J Virol. 2000 Jul;74(13):5968-81. doi: 10.1128/jvi.74.13.5968-5981.2000.
8
Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.实验感染马属动物在急性疾病和无症状感染期间马传染性贫血病毒持续感染和活跃复制的组织部位。
J Virol. 2000 Apr;74(7):3112-21. doi: 10.1128/jvi.74.7.3112-3121.2000.
9
Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.通过改变N-连接糖基化的细胞外包膜糖蛋白中的序列变化,在体内选择猿猴/人类免疫缺陷病毒SHIVSF33A变体的中和抗性。
J Virol. 1999 Jul;73(7):5294-300. doi: 10.1128/JVI.73.7.5294-5300.1999.
10
Characterization of a neutralization-escape variant of SHIVKU-1, a virus that causes acquired immune deficiency syndrome in pig-tailed macaques.SHIVKU-1的一种中和逃逸变体的特征,SHIVKU-1是一种在食蟹猕猴中引发获得性免疫缺陷综合征的病毒。
Virology. 1999 Mar 30;256(1):54-63. doi: 10.1006/viro.1999.9605.